ES2148561T3 - Prevencion y curacion de enfermedades alergicas de tipo i. - Google Patents

Prevencion y curacion de enfermedades alergicas de tipo i.

Info

Publication number
ES2148561T3
ES2148561T3 ES95933609T ES95933609T ES2148561T3 ES 2148561 T3 ES2148561 T3 ES 2148561T3 ES 95933609 T ES95933609 T ES 95933609T ES 95933609 T ES95933609 T ES 95933609T ES 2148561 T3 ES2148561 T3 ES 2148561T3
Authority
ES
Spain
Prior art keywords
branched
linear
allergic diseases
type
cure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95933609T
Other languages
English (en)
Inventor
Yukio Amano
Yuko Mizushima
Kenji Ogata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis UK Holdings Ltd
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Application granted granted Critical
Publication of ES2148561T3 publication Critical patent/ES2148561T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/655Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

COMPOSICION PARA PREVENIR O TRATAR ENFERMEDADES ALERGICAS DEL TIPO I QUE CONTIENEN COMO INGREDIENTE ACTIVO UN COMPUESTO DE ANILIDO REPRESENTADO POR LA FORMULA GENERAL (I), UN ESTEREOISOMERO DE LA MISMA, O UNA SAL ACEPTABLE FARMACEUTICAMENTE DE LA MISMA; DONDE R{SUB,1} REPRESENTA TRIFLUOROMETIL, HALOGENO O CIANO; R{SUB,2} REPRESENTA HIDROGENO O ALQUIL C{SUB,1}-C{SUB,4} LINEAL O RAMIFICADO, Y R{SUB,3} REPRESENTA UN GRUPO REPRESENTADO POR LA FORMULA GENERAL (II) O (III), DONDE R{SUB,4} REPRESENTA ALQUIL C{SUB,1}-C{SUB,4} LINEAL O RAMIFICADO, ALQUENIL C{SUB,2}C{SUB,6} LINEAL O RAMIFICADO, ALQUINIL C{SUB,2}-C{SUB,6} LINEAL O RAMIFICADO, O CICLOALQUIL C{SUB,3}-C{SUB,7}. LA COMPOSICION PUEDE PREVENIR DE FORMA RADICAL O TRATAR ENFERMEDADES ALERGICAS DEL TIPO I MEDIANTE LA INHIBICION DE LA PRODUCCION DE IGE COMO CAUSA DIRECTA DE ESTAS ENFERMEDADES.
ES95933609T 1994-10-17 1995-10-04 Prevencion y curacion de enfermedades alergicas de tipo i. Expired - Lifetime ES2148561T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25029394 1994-10-17

Publications (1)

Publication Number Publication Date
ES2148561T3 true ES2148561T3 (es) 2000-10-16

Family

ID=17205757

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95933609T Expired - Lifetime ES2148561T3 (es) 1994-10-17 1995-10-04 Prevencion y curacion de enfermedades alergicas de tipo i.

Country Status (19)

Country Link
US (1) US5814649A (es)
EP (1) EP0787491B1 (es)
KR (1) KR100365064B1 (es)
AT (1) ATE194912T1 (es)
AU (1) AU695907B2 (es)
CA (1) CA2202904C (es)
DE (1) DE69518159T2 (es)
DK (1) DK0787491T3 (es)
ES (1) ES2148561T3 (es)
FI (1) FI971584A (es)
GR (1) GR3034413T3 (es)
HU (1) HU222888B1 (es)
IL (1) IL115617A (es)
NO (1) NO315928B1 (es)
NZ (1) NZ293691A (es)
PT (1) PT787491E (es)
TW (1) TW429146B (es)
WO (1) WO1996011682A1 (es)
ZA (1) ZA958708B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT987256E (pt) * 1997-08-08 2002-03-28 Aventis Pharma Gmbh Forma cristalina da n-(4-trifluorometilfenil)-5-metil-isoxazol-4-carboxamida
ATE372320T1 (de) 1998-02-19 2007-09-15 Kowa Co Cyclische amidderivate
US6303652B1 (en) 1998-08-21 2001-10-16 Hughes Institute BTK inhibitors and methods for their identification and use
JP2004504264A (ja) * 2000-01-07 2004-02-12 ユニバーシティ オブ シンシナティ Th1又はth2リンパ球に制御される免疫応答の選択的活性化
US6849260B2 (en) 2000-08-18 2005-02-01 Amgen Inc. Methods and compositions for treating IgE-related disease using NNT-1 inhibitors
AU2001236361A1 (en) * 2000-10-20 2002-05-06 Parker Hughes Institute Treatment of asthma with lfm analogues
US6706703B2 (en) 2001-06-29 2004-03-16 Kowa Co., Ltd. Bis(5-aryl-2-pyridyl) derivatives
US6890940B2 (en) 2001-06-29 2005-05-10 Kowa Co., Ltd. Bis(2-aryl-5-pyridyl) derivatives
US8283515B2 (en) 2002-05-03 2012-10-09 Sca Hygiene Products Ab Absorbent article containing a skin conditioning agent
RU2012115459A (ru) 2009-09-18 2013-10-27 Санофи Таблетируюмый препарат (4'-трифторметилфенил)амида (z)-2-циано-3-гидрокси-бут-2-еноевой кислоты с улучшенной устойчивостью

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
DE4127737A1 (de) * 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
TW314467B (es) * 1993-03-31 1997-09-01 Hoechst Ag

Also Published As

Publication number Publication date
AU695907B2 (en) 1998-08-27
AU3618695A (en) 1996-05-06
IL115617A0 (en) 1996-01-19
NO315928B1 (no) 2003-11-17
US5814649A (en) 1998-09-29
ATE194912T1 (de) 2000-08-15
FI971584A0 (fi) 1997-04-15
DE69518159D1 (de) 2000-08-31
WO1996011682A1 (fr) 1996-04-25
HUT77135A (hu) 1998-03-02
EP0787491A4 (en) 1998-09-30
NO971743L (no) 1997-04-16
CA2202904A1 (en) 1996-04-25
GR3034413T3 (en) 2000-12-29
EP0787491A1 (en) 1997-08-06
KR100365064B1 (ko) 2003-04-11
EP0787491B1 (en) 2000-07-26
CA2202904C (en) 2006-12-19
NO971743D0 (no) 1997-04-16
FI971584A (fi) 1997-04-15
HU222888B1 (hu) 2003-12-29
IL115617A (en) 1999-11-30
ZA958708B (en) 1996-05-14
NZ293691A (en) 1999-07-29
KR970706811A (ko) 1997-12-01
PT787491E (pt) 2000-11-30
DK0787491T3 (da) 2000-10-16
DE69518159T2 (de) 2002-01-03
TW429146B (en) 2001-04-11

Similar Documents

Publication Publication Date Title
DE69331414D1 (de) Depsipeptide, herstellung und anwendung
TW430660B (en) Novel benzindole derivatives for neuron cell protection, processes for production, and the pharmaceutical compounds containing them
ATE384524T1 (de) Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
DE69725113D1 (de) Azetidin- und Pyrrolidinderivate
ES2148561T3 (es) Prevencion y curacion de enfermedades alergicas de tipo i.
DE69707372T2 (de) Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne
ES2073258T3 (es) Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica.
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ES2191763T3 (es) Inhibidor del desarrollo de dependencia/tolerancia a un agente analgesico narcotico.
AU7424394A (en) 3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
DE69910738D1 (de) Fungizide zusammensetzung enthaltend ein n-benzoyl-n&#39;-phenyl-harnstoff derivat
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
ES2116528T3 (es) Nuevo compuesto, la leustroducsina h, su preparacion y su utilizacion terapeutica.
ATE223418T1 (de) 4&#39;-substituierte-4&#39;,5&#39;-dihydropsoralene und deren therapeutische verwendung

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 787491

Country of ref document: ES